January 18, 2013
The U.S. Food and Drug Administration on Friday urged a Washington federal judge to nix Cumberland Pharmaceuticals Inc.'s bid to block a generic version of its acetaminophen-overdose treatment after it changed the formula over safety concerns, saying Cumberland's suit would unfairly extend its monopoly on the drug.
November 15, 2012
Cumberland Pharmaceuticals Inc. on Tuesday moved to block the U.S. Food and Drug Administration's approval of InnoPharma Inc.'s generic version of Cumberland's acetaminophen-overdose treatment Acetadote, claiming the approval could put potentially harmful versions of the drug on the market.